Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Revvity Omics, |
RCV001780790 | SCV002023244 | likely pathogenic | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV004801048 | SCV005422090 | uncertain significance | not specified | 2024-10-25 | criteria provided, single submitter | clinical testing | Variant summary: CLCN1 c.494T>G (p.Val165Gly) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251474 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.494T>G has been reported in the literature in individuals affected with Myotonia congenita (Meyer-Kleine_1995). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function (Zhang_2000), however, it does not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 8533761, 10690989). ClinVar contains an entry for this variant (Variation ID: 1324085). Based on the evidence outlined above, the variant was classified as uncertain significance. |